Furthermore, we show a correlation between higher expression of Eomes in CD4+ Th cells in SPMS patients at the baseline measurement and clinical progression of the disease after one year, measured by changes in EDSS. The gene discussed is CD4; the disease is secondary progressive multiple sclerosis.